Ravi Agarwal M.D., Frank Z. Stanczyk Ph.D., Rachel Mandelbaum M.D., Richard J. Paulson M.D., Lynda K. McGinnis Ph.D., Sharon A. Winer M.D.
{"title":"Prevalence of endometrial hyperplasia and carcinoma in women with polycystic ovarian syndrome","authors":"Ravi Agarwal M.D., Frank Z. Stanczyk Ph.D., Rachel Mandelbaum M.D., Richard J. Paulson M.D., Lynda K. McGinnis Ph.D., Sharon A. Winer M.D.","doi":"10.1016/j.xfre.2025.06.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To measure the prevalence of EH and EC in women with PCOS.</div></div><div><h3>Design</h3><div>Prospective, cross-sectional study.</div></div><div><h3>Subjects</h3><div>208 women diagnosed with PCOS according to the Rotterdam criteria. Patients were excluded if all study variables were not measured/collected, or if they were on hormone treatment within 3 months of diagnosis.</div></div><div><h3>Intervention</h3><div>All women diagnosed with PCOS underwent an endometrial biopsy in the outpatient setting.</div></div><div><h3>Main Outcome Measures</h3><div>The primary outcome was the prevalence of a normal endometrium, nonatypical EH (NAEH), atypical EH (endometrial intraepithelial neoplasia (EIN)), or EC on endometrial biopsy.</div></div><div><h3>Results</h3><div>146 PCOS women (70%) had a normal endometrium, 19 (9%) had NAEH, 31 (15%) had EIN, and 12 (6%) had EC. Compared with women with a normal endometrial biopsy, patients with EC were significantly older (32.1 vs. 28.8 years) and had lower levels of free and total testosterone (5.2 vs. 9.3 pg/mL and 33.9 vs. 60.9 ng/dL, respectively).</div></div><div><h3>Conclusion</h3><div>There is a high prevalence of EH and EC in PCOS women. The high risk of EIN and EC in an unselected population with PCOS strongly suggests that endometrial biopsy should be a part of the routine evaluation of women >20 years old diagnosed with PCOS.</div></div>","PeriodicalId":34409,"journal":{"name":"FS Reports","volume":"6 3","pages":"Pages 394-398"},"PeriodicalIF":2.2000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FS Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666334125001011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To measure the prevalence of EH and EC in women with PCOS.
Design
Prospective, cross-sectional study.
Subjects
208 women diagnosed with PCOS according to the Rotterdam criteria. Patients were excluded if all study variables were not measured/collected, or if they were on hormone treatment within 3 months of diagnosis.
Intervention
All women diagnosed with PCOS underwent an endometrial biopsy in the outpatient setting.
Main Outcome Measures
The primary outcome was the prevalence of a normal endometrium, nonatypical EH (NAEH), atypical EH (endometrial intraepithelial neoplasia (EIN)), or EC on endometrial biopsy.
Results
146 PCOS women (70%) had a normal endometrium, 19 (9%) had NAEH, 31 (15%) had EIN, and 12 (6%) had EC. Compared with women with a normal endometrial biopsy, patients with EC were significantly older (32.1 vs. 28.8 years) and had lower levels of free and total testosterone (5.2 vs. 9.3 pg/mL and 33.9 vs. 60.9 ng/dL, respectively).
Conclusion
There is a high prevalence of EH and EC in PCOS women. The high risk of EIN and EC in an unselected population with PCOS strongly suggests that endometrial biopsy should be a part of the routine evaluation of women >20 years old diagnosed with PCOS.